Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | RARA | P10276 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | HGFAC | Q04756 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | KDM2B | Q8NHM5 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26083061 | 0.90 | GAA (0.46) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL26083073 | 0.88 | GAA (0.46) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL26083093 | 0.83 | GAA (0.42) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL1535633 | 0.76 | GAA (0.61) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL13554256 | 0.74 | GAA (0.53) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL565530 | 0.74 | GAA (0.59) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL26083007 | 0.73 | GAA (0.43) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL18072216 | 0.73 | GAA (0.57) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL21236182 | 0.73 | GAA (0.52) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL26083091 | 0.72 | GAA (0.46) | GAAHTTTSHRALDH1A1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | HNRNPU, CBR1, CBR3 | GAA 4805/4885HTT 1040/4885TSHR 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.